We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+38.72%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$499M
AUM Growth
Cap. Flow
+$459M
Cap. Flow %
92.04%
Top 10 Hldgs %
79.61%
Holding
26
New
26
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 5.59%
2 Technology 4.12%
3 Financials 3.74%
4 Industrials 1.76%
5 Consumer Discretionary 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTLA icon
26
Intellia Therapeutics
NTLA
$1.67B
$3.16M 0.63%
+58,010
New +$2.11M

Similar funds

Brevan Howard Capital Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Brevan Howard Capital Management, which disclosed 26 positions worth $499M. Its ten largest holdings account for 80% of the portfolio.

Its largest position is VanEck Gold Miners ETF: 1,000,000 shares worth $36M.

By sector, the portfolio is most concentrated in Healthcare at 5.6% of assets, followed by Technology and Financials.

  • Brevan Howard Capital Management's largest Q4 2020 buy was VanEck Gold Miners ETF: 1,000,000 shares worth $36M.
  • Brevan Howard Capital Management's ten largest holdings make up 80% of its $499M portfolio in Q4 2020.
  • Brevan Howard Capital Management disclosed 26 positions in Q4 2020, its first 13F filing on record.

Based on Brevan Howard Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.